Demonstration of developing myelodysplasia/acute myeloid leukaemia in haematologically normal patients after high-dose chemotherapy and autologous bone marrow transplantation using X-chromosome inactivation patterns

British Journal of Haematology

Volumn 93, Issue 1, 1996, Pages 53-58

  Gale, R E ^a   Bunch, C ^b   Moir, D J ^c   Patterson, K G ^a   Goldstone, A H ^a   Linch, D C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c MILTON KEYNES GENERAL HOSPITAL   (United Kingdom)

Author keywords

ABMT; Secondary MDS AML; X chromosome inactivation patterns

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; LOMUSTINE; MELPHALAN; PREDNISONE; PROCARBAZINE; TIOGUANINE; VINBLASTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CASE REPORT; FEMALE; HUMAN; HUMAN CELL; MYELODYSPLASIA; PRIORITY JOURNAL; T LYMPHOCYTE; X CHROMOSOME;

ACUTE DISEASE; ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; DOSAGE COMPENSATION, GENETIC; HODGKIN DISEASE; HUMANS; LEUKEMIA, MYELOID; MALE; MYELODYSPLASTIC SYNDROMES; POSTOPERATIVE PERIOD; PROGNOSIS; TRANSPLANTATION, AUTOLOGOUS;

EID: 0029939921     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.4751014.x     Document Type: Article

References (28)

1. Allen, R.C., Zoghbi, H.Y., Moseley, A.B., Rosenblatt, H.M. & Belmont, J.W. (1992) Methylation of Hpa II and Hha I sites near the polymorphic CAG repeat in the androgen-receptor gene correlates with X-chromosome inactivation. American Journal of Human Genetics, 51, 1229-1239.
2. Browne, P.V., Lawler, M., Humphries, P. & McCann, S.R. (1991) Donor-cell leukemia after bone marrow transplantation for severe aplastic anemia. New England Journal of Medicine, 325, 710-713.
3. Busque, L., Maragh, M., DeHart, D., McGarigle, C., Vose, J., Armitage, J., Meisinger, D., Wheeler, C., Gaines, L., Belanger, R., Habel, F., Dunbar, C., Champagne, M., Gross, W., Weinstein, H., Antin, J.H. & Gilliland, D.G. (1993) Clonality of bone marrow repopulation after allogeneic and autologous bone marrow transplantation (ABMT). Blood, 82, (Suppl. 1), 457a.
4. Cachia, P.G., Culligan, D.J., Clark, R.E., Whittaker, J.A., Jacobs, A. & Padua, R.A. (1993) Clonal hemopoiesis following cytotoxic therapy for lymphoma, Leukemia, 7, 795-800.
5. Chanarin, I. (ed.) (1982) Immunological markers. In: Laboratory Haematology: an Account of Laboratory Techniques. Churchill Livingstone, Edinburgh.
6. Darrington, D.L., Vose, J.M., Anderson, J.R., Bierman, P.J., Bishop, MR., Chan, W.C., Morris, M.E., Reed, E.C., Sanger, W.G., Tarantolo, S.R., Weisenburger, D.D., Kessinger, A. & Armitage, J.O. (1994) Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies. Journal of Clinical Oncology, 12, 2527-2534.
7. Devereux, S. (1991) Therapy-associated leukemia. Blood Review's, 5, 138-145.
8. Devereux, S., Selassie, T.G., Vaughan Hudson, G., Vaughan Hudson, B. & Linch, D.C. (1990) Leukaemia complicating treatment for Hodgkin's disease: the experience of the British National Lymphoma Investigation. British Medical Journal. 301, 1077-1080.
9. Fey, M.F., Pilkington, S.P., Summers, C. & Wainscoat, J.S. (1987) Molecular diagnosis of haematological disorders using DNA from stored bone marrow slides. British Journal of Haematology, 67, 489-492.
10. Gale, R.E. & Wainscoat, J.S. (1993) Clonal analysis using X-linked DNA polymorphisms. British Journal of Haematology, 85, 2-8.
11. Gale, R.E., Wheadon, H., Boulos, P. & Linch, D.C. (1994) Tissue specificity of X-chromosome inactivation patterns. Blood. 83, 2899-2905.
12. Gale, R.E., Wheadon, H., Goldstone, A.H., Burnett, A.K. & Linch, D.C. (1993) Frequency of clonal remission in acute myeloid leukaemia. Lancet. 341, 138-142.
13. Gale, R.E., Wheadon, H., Goldstone, A.H. & Linch, D.C. (1992) X-chromosome inactivation patterns in haemopoietic cells before and after high dose chemotherapy/radiotherapy and autologous hone marrow transplantation. Proceedings from the 24th Congress of the International Society of Haematology, London, p. 50.
14. Gale, R.E., Wheadon, H. & Linch, D.C. (1991) X-chromosome inactivation patterns using HPRT and PGK polymorphisms in haematologically normal and post-chemotherapy females. British Journal of Haematology, 79, 193-197.
15. Greene, N.H., Young, R.C., Merrill, J.M. & DeVita, V.T. (1983) Evidence of a treatment of dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin's lymphoma. Cancer Research, 43, 1891-1898.
16. Jowitt, S.N., Liu Yin, J.A. & Saunders, M.J. (1993) Relapsed myelodysplastic clone differs from acute onset clone as shown by X-linked DNA polymorphism patterns in a patient with acute myeloid leukemia. Blood, 82, 613-618.
17. Maniatis, T., Fritsch, K. & Sambrook, J. (1982) Molecular Cloning, a Laboratory Manual. Cold Spring Harbor Laboratory, New York.
18. McMillan, A.K., Goldstone, A.H., Linch, D.C., Gribben, J.G., Patterson, K.G., Richards, J.D.M.R., Franklin, I., Boughton, B.J., Milligan, D.W., Leyland, M., Hutchison, R.M. & Newland, A.C. (1990) High-dose chemotherapy and autologous bone marrow transplantation in acute myeloid leukemia. Blood, 76, 480-488.
19. Miller, J.S., Arthur, D.C., Litz, C.E., Neglia, J.P., Miller, W.J. & Weisdorf, D.J. (1994) Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy. Blood, 83, 3780-3786.
20. Nash, R., Storb, R. & Neiman, P. (1988) Polyclonal reconstitution of human marrow after allogeneic bone marrow transplantation. Blood. 72, 2031-2037.
21. Newburger, P.E., Latt, S.A., Pesando, J.M., Gustashaw, K., Powers, M., Chaganti, R.S.K. & O'Reilly, R.J. (1981) Leukemia relapse in donor cells after allogeneic bone-marrow transplantation. New England Journal of Medicine, 304, 712-714.
22. Pedersen-Bjergaard, J., Ersboll, J., Sorensen, M.H., Keiding, N., Larsen, S.O., Philip, P., Larsen, M.S., Schultz, H. & Nissen, N.I. (1985) Risk of acute nonlymphocytic leukaemia and preleukaemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Annals of Internal Medicine, 103, 195-200.
23. Saunders, M.J., Jowitt, S.N. & Liu Yin, J.A. (1995) Clonality studies in patients undergoing allogeneic and autologous bone marrow transplantation for hematological malignancies. Bone Marrow Transplantation, 15, 81-85.
24. Stone, R.M., Neuberg, D., Soiffer, R., Takvorian, T., Whelan, M., Rabinowe, S.N., Aster, J.C., Leavitt, P., Mauch, P., Freedman, A.S. & Nadler, L.M. (1994) Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma. Journal of Clinical Oncology, 12, 2555-2542.
25. Traweek, S.T., Slovak, M.L., Nademanee, A.P., Brynes, R.K., Niland, J.C. & Forman, S.J. (1994) Clonal karyolypic hematopoietic cell abnormalities occurring after autologous bone marrow trans-plantation for Hodgkin's disease and non-Hodgkin's lymphoma. Blood, 84, 957-963.
26. Turhan, A.G., Humphries, R.K., Phillips, G.L., Eaves, A.C. & Eaves, C.J. (1989) Clonal hematopoiesis demonstrated by X-linked DNA polymorphisms after allogeneic bone marrow transplantation. New England Journal of Medicine, 320, 1655-1661.
27. Witherspoon, R.P., Schubach, W., Neiman, P., Martin, P. & Thomas, E.D. (1985) Donor cell leukemia developing 6 years after marrow grafting for acute leukemia. Blood, 65, 1172-1174.
28. Yunis, J.J., Lobell, M., Arnesen, M.A., Oken, M.M., Mayer, M.G., Rydell, R.E. & Brunning, R.D. (1988) Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia. British Journal of Haematology, 68, 189-194.